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Objective. Get a working method to help us improve nursing care in breast carcinoma radiodermatitis.Methods. An observational,
longitudinal and prospective study in 2012 on 35 women diagnosed with breast cancer radiotherapy after conservative surgery. To
evaluate the degree of radiationdermatitiswasused scale RTOG/EORTC. To locatewhere the ﬁrst signs orwhere further intensiﬁes
the degree of radiation dermatitis, was performed in addition to the general evaluation of the breast, an assessment by area.
Have differentiated localized in 9 areas: axilla, submammary fold, nipple, areola, supraclavicular and each of the quadrants of
the breast. The assessment of the signs of breast radiodermatitis was conducted in weekly from the ﬁrst to the last and one
month after stopping treatment.Results. During theweekly review, in 24 of the 35women appeared radiodermatitis degrees higher
when this assessment was carried out in speciﬁc areas when performed in the general assessment of the breast. Performing
radiodermatitis averages with RTOG scale, the overall breast showed a mean of 1, compared to 1.25 presented than the fold
and armpit and 1.11 was obtained in the nipple and areola.Conclusions. This evaluation of the breast radiodermatitis focused
differentiation gives us a much better risk areas as care to apply. Furthermore, we can observe the evolution and determine
speciﬁc areas of care against the valuation of the breast as a whole.
http://dx.doi.org/10.1016/j.rpor.2013.03.096
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Objective. To assess the effect of close monitoring and specialized care on the factors that inﬂuence the development of radio-
dermatitis in patients with breast irradiation.
Material and methods. Between December 2011 and June 2012 was an observational, longitudinal and prospective study in 35
patients with indications for breast irradiation. Weekly are evaluated the signs and symptoms of radiation dermatitis during
and for one month after stopping treatment by nursing unit in radiotherapy. To evaluate the inﬂuence of the following factors:
(1) Type of treatment and fractionation. (2) Age of the patient. (3) Areas of friction and high humidity areas. (4) Breast size. (5)
Nutritional status. (6) Skin phototype. (7) Application of metal-based cosmetics. To determine the degree of radiation dermatitis
have used the scale of the RTOG/EORTC.
Results. Of the 35 participants, 24 had in areas of friction or rubbing an increased degree of radiation dermatitis. Of all the factors
analyzed no differences by different dose fractionation, or age, breast size, nutritional status, skin type or increased by applying
zinc oxide in the treatment areas.
Conclusions. Of all the factors analyzed only be attributed to increased toxicity areas with excess moisture or friction such as the
underarm, the fold, the nipple and areola.
http://dx.doi.org/10.1016/j.rpor.2013.03.097
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Introduction. Treatment to thewhole breastwith standard tangencial ﬁelds produces rather inhomogeneousdosedistributionsdue
to the variations in thickness across the target volume. The underlying ribs, lung and heart are in part included within the same
isodose as the target volume and hot spots are often found in areas of reduced tissue thickness. These dose inhomogeneities
may lead to increased late skin toxicity and increased cardiac and lung morbidity. IMRT has the potential to improve target
coverage and reduce inhomogeneities observed within the breast (and regional lymph nodes) and enables dose reduction to
normal structures with the potential to reduce treatment toxicity improving cosmesis.
Objectives. We present the initial experience of the ﬁrst breast cancer patients treated with IMRT in our centers in Málaga and
Granada.
Material and methods. 16 patients with breast cancer were referred to receive radiotherapy to our clinics. After individualized
evaluation in a clinical meeting, the patients were proposed to undergo IMRT treatment.
Results. Patient selection criteria: Left breast: 9, unfavourable chest wall: 4, patient decision: 2, irregular breast: 1 patient. Stage:
Early breast cancer: 10 patients, advanced breast cancer: 6 patients. Positive axillary nodes: 6 patients (all of them received
radiotherapy at supraclavicular area). Median prescribed dose to the whole breast was 42.56Gy, with fractionation of 2.66Gy. 12
patients received additional boost to the tumor bed, in 7 patients it was an integrated boost (median dose administered was
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50.56Gy). Median prescribed dose to the supraclavicular area was 42.56. 13 patients were treated with Step and shot and 3, with
VMAT.
Conclusions. Longer follow up will provide data on late toxicity and tumour recurrence in our serie; and likewise, further clinical
study remains important to thoroughly deﬁne the appropriate clinical setting and patient selection criteria for IMRT in breast
cancer.
http://dx.doi.org/10.1016/j.rpor.2013.03.098
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Introduction. The goal of radiation therapy is to decrease toxicity and achieve higher tumor control by increasing the dose and
lowering its margins. Thanks to the new technologies and locking systems we are getting closer to this goal.
Objective. To demonstrate the dose difference received by the organs at risk near the volume in a patient with breast tumor
depending on whether it is treated with the Inclined Plane Immobilizer or Thorax Immobilizer.
Methodology. We conducted a series of CT scan simulations in patients with the Inclined Plane Immobilizer and the Thorax
Immobilizer in order to demonstrate the existing differences in treatment planning. The doctor painted the volumes on both CT
scans and the physics service made the relevant calculations on both treatment plannings in order to measure the differences.
Conclusions. We have observed signiﬁcant differences in terms of the amount of dose reaching the organs at risk near the volume
depending on the immobilization system used.
http://dx.doi.org/10.1016/j.rpor.2013.03.099
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Introduction. IMRT with simultaneous or sequential integrated boost (SIB) is feasible in the treatment of bilateral breast cancer.
This technique can spare organs at risk and is able to give a homogeneous dose distribution in breast volume and surgical bed
(Boost).
Method. Between 2009 and 2012, 6 patients with bilateral breast cancer, 3 received IMRT+SIB, 1 IMRT sequential boost with
electron beam and 2 were treated with three-dimensional radiotherapy. The prescribed dose in integrated boost was 62.5Gy,
breast and supraclavicular fossa (SCF) 50Gy in 25 sessions and 30 sessions in sequential boost. The studied homogeneity index
(HI) was deﬁned as: (D5%−D95%)/breast mean dose. Also was calculated conformity index (CI): V95%/VPTV (both volumes in
cm3, total breast and boost volumes).
Results. 4 patients: TNM variable: TIS T3 N0–N2, no predominant tumor location. Three patients were treated by conserving
surgery+ sentinel lymph node biopsy or lymphadenectomy and one suffered modiﬁcated radical mastectomy. All patients
received adjuvant chemotherapy and hormone treatment. Dosimetric data (range): chest wall volume: 185–215 cm3, breast V:
117–2168 cm3, Boost V: 60–430cm3, SCF V: 234-579 cm3. D107: 0–6.95Gy, Mean Dose 50:53Gy (50.3–56.8Gy), Mean Dose 60: 60.1Gy,
Mean Dose 62.5: 62.7Gy (62.5–63.13Gy). V95: 92.2–97.1%, D5: 52.67–64.4Gy, D95: 48–59.4Gy. CI = 0.08–0.15, HI: 0.75–0.95. Organs
at risk: left lung volume: 890–1110 cm3, left V20=23.9% (17–28.3), left lung mean dose: 15.52Gy (11.2–18.6), Right lung volume:
1162–1296 cm3, right V20 17.75 (17.9–26.9). 11.2–18.6Gy, right lung mean dose: 15.52Gy (11.9–18.6). Heart volume: 334–590 cm3,
V25: 0.7%, heart mean dose: 9.3Gy (4.2–18.7). Left coronary artery (LCA) volume: 2.7–4.9 cm3, LCA mean dose: 7.9Gy (5.3–15.7),
mean LCA maximal dose: 10.31Gy (6.9–17.9).
Conclusion. IMRT in bilateral breast cancer is preferred for individual medical situations. The calculate of homogeneity and
conformity index is very important in treatment quality and it must be evaluated for each patient.
http://dx.doi.org/10.1016/j.rpor.2013.03.100
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Objective. The objective is to compare two techniques for the treatment planning of an internal mammary chain and left breast
mastectomy and axillary and supraclavicular lymph nodes irradiation with two techniques: 3DRT alone (1), versus a combination
of IMRT for mastectomy and internal mammary chain and 3DRT for lymph nodes (2).
